Skip to main content

Soft Mist Inhalers
& Soft Nasal Sprays

At Resyca we make syringe and cartridge based inhaler devices and nasal sprays for liquid formulations. We want to offer the best possible inhalation & nasal treatments while reducing the impact on our environment. Resyca can make a difference to both.
About Us

LEADING THE SOFT MIST

TRANSITION

Resyca is redefining drug delivery through innovative soft mist inhalation technology.

Existing inhalers that use propellants or dry powder based formulations are generally intended for potent medications that require micrograms to be effective. In contrast, new drugs such as biologics, in most cases, require much higher dosages. Resyca technology can aerosolise many of these drugs, such as mRNA without degradation and deliver high doses. 

PFSI

The PFSITM, a pre-filled syringe inhaler is based on a 1mL glass syringe. The medication is already in the device and the patient can start using immediately.

The glass syringe is proven primary packaging that improves drug stability for complex biological formulations using existing filling lines.

Learn more

Ultra Soft Nasal Pump Spray

The Ultra Soft Nasal Pump Spray delivers a fine, low-velocity mist with unmatched control. Designed for accurate deposition and reliable performance, it sets a new standard for advanced nasal drug delivery such as CNS therapies, nasal vaccines, or sensitive biologics.

Learn more

WHY RESYCA?

Advancing Delivery

Set your therapies apart with our IP-protected soft mist technology. Benefit from efficient delivery to the lungs or targeted administration to nasal cavities, supporting your drug-device combination products.

Learn more

Time to Market

Accelerate your path to commercialisation. Our technology leverages existing liquid formulations, reducing the need for complex reformulation and shortening development timelines.

Learn more

Patient Focused

Resyca’s soft mist inhalers are designed to support better patient outcomes. The gentle, slow-moving mist and intuitive design help patients use their device correctly, reducing the risk of errors. 

Learn more

Latest News

View all
Contact